Clinical trial registry record

Cocoa Supplementation, Inflammaging, and Epigenetic Aging

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Unknown.
Evidence
Registered phase 4 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated August 22, 2022.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05510375
Last registry update
August 22, 2022
Status
Unknown
Phase
Phase 4
Sponsor
Augusta University
Enrollment
21442
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 4
Study design
RANDOMIZED · FACTORIAL · PREVENTION · DOUBLE
Evidence population
Human clinical study registration
Participants
21442
Population
ALL · 60 Years
Duration
2015-06-01 to 2023-09-30
Intervention
Cocoa extract; Multivitamin; Cocoa extract placebo; Multivitamin placebo
Comparator
Cocoa extract + multivitamin; Cocoa extract + multivitamin placebo; Cocoa extract placebo + multivitamin; Cocoa extract placebo + multivitamin placebo
Outcomes measured
Epigenetic age acceleration — 2 years; Inflammaging — 2 years; Blood pressure — 2 years; Body mass index — 2 years; Pulse wave velocity — 2 years
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 4A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Chronic inflammation · 100%Title contains controlled term: inflammaging. Abstract contains controlled term: inflammaging. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

chronic inflammation
Open primary sourceExport JSON